MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

Search

Smith & Nephew PLC ADR

Закрыт

31.72 -2.67

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

31.52

Макс.

32.62

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

22.091

56.063

Дивидендная доходность

2.48

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+8.77% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.48%

2.45%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.8B

13B

Предыдущая цена открытия

34.39

Предыдущая цена закрытия

31.72

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 апр. 2026 г., 23:17 UTC

Отчет

Samsung Forecasts Record First-Quarter Operating Profit

6 апр. 2026 г., 23:00 UTC

Популярные акции

Stocks to Watch: Health Insurers, Mawson, Owlet

6 апр. 2026 г., 22:13 UTC

Главные движущие силы рынка

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 апр. 2026 г., 21:46 UTC

Приобретения, слияния, поглощения

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 апр. 2026 г., 17:09 UTC

Главные движущие силы рынка

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 апр. 2026 г., 16:56 UTC

Главные новостные события

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 апр. 2026 г., 14:47 UTC

Главные движущие силы рынка

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 апр. 2026 г., 00:00 UTC

Главные новостные события

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 апр. 2026 г., 23:58 UTC

Обсуждения рынка
Главные новостные события

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 апр. 2026 г., 23:50 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 апр. 2026 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 апр. 2026 г., 23:15 UTC

Обсуждения рынка

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 апр. 2026 г., 22:52 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

6 апр. 2026 г., 22:52 UTC

Обсуждения рынка

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 апр. 2026 г., 22:14 UTC

Обсуждения рынка

Correction to Live Cattle Futures Article

6 апр. 2026 г., 20:56 UTC

Обсуждения рынка

Mexican Private Consumption Fell in January -- Market Talk

6 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Energy & Utilities Roundup: Market Talk

6 апр. 2026 г., 20:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

6 апр. 2026 г., 19:58 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

6 апр. 2026 г., 19:58 UTC

Обсуждения рынка

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 апр. 2026 г., 19:11 UTC

Обсуждения рынка

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 апр. 2026 г., 19:06 UTC

Обсуждения рынка

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 апр. 2026 г., 19:03 UTC

Обсуждения рынка

Global Energy Roundup: Market Talk

6 апр. 2026 г., 19:03 UTC

Обсуждения рынка

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 апр. 2026 г., 18:36 UTC

Приобретения, слияния, поглощения

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 апр. 2026 г., 17:59 UTC

Обсуждения рынка
Главные новостные события

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 апр. 2026 г., 17:13 UTC

Приобретения, слияния, поглощения

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 апр. 2026 г., 16:33 UTC

Обсуждения рынка

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 апр. 2026 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

6 апр. 2026 г., 14:59 UTC

Отчет

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

8.77% рост

Прогноз на 12 месяцев

Средняя 34.96 USD  8.77%

Максимум 35 USD

Минимум 34.91 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat